<p>APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the &micro;-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy</p>Eugene R. Viscusi, Neil Singla, Franck Skobieranda et al.|Journal of Pain Research|2019Cited by 165